Revalesio’s RNS60 program signals renewed momentum in adjunctive stroke therapeutics
Revalesio presents new RNS60 stroke data showing reduced brain tissue loss and shorter hospital stays. Discover what this could mean for stroke drug development.
What the FDA IDE approval for ThermoSuit means for the future of neuroprotective stroke therapy
Life Recovery Systems begins pivotal ThermoSuit stroke trial to test rapid cooling therapy. Discover what this could mean for neuroprotection in ischemic stroke.